Loading clinical trials...
Loading clinical trials...
Evaluating the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC® System Compared to Other Therapeutic Interventions for the Treatment of Renal Stones: a Prospective, Observational Trial
The goal of this clinical trial is to evaluate the effectiveness and safety of Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System versus other commonly used renal-stone interventions.
Up to 25 sites, and up to 250 subjects will be prospectively enrolled for phase 1: CVAC and FANS cohorts.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
March 16, 2026
Primary Completion Date
April 1, 2028
Completion Date
April 1, 2029
Last Updated
March 12, 2026
1,000
ESTIMATED participants
CVAC® SYSTEM
DEVICE
FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS)
DEVICE
DIRECT IN-SCOPE SUCTION (DISS) IN FLEXIBLE URETEROSCOPY (FURS)
DEVICE
URETEROSCOPY (URS) WITHOUT SUCTION
PROCEDURE
PERCUTANEOUS NEPHROLITHOTOMY (PCNL)
PROCEDURE
Lead Sponsor
Calyxo, Inc.
NCT07076589
NCT07275879
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions